Sterile, Liquid and Injectable Manufacturing Equipment

Sterile products leave no margin for error. This section covers the equipment that keeps products sterile from component washing to visual inspection, how EU GMP Annex 1 shapes those choices, and the machines used for oral liquids, creams and ointments.

20 guides · By the Hello Pharma Editorial Team · Last updated 19 November 2026

Sterile manufacturing follows one of two routes. Terminal sterilization sterilizes the product in its final container, usually by moist heat. Aseptic processing sterilizes the product, containers and closures separately, then brings them together in a Grade A environment. Most biologics and many small-molecule injectables must be made aseptically, and that is where barrier technology, filling accuracy and validation carry the most weight.

The guides below cover filling and stoppering, lyophilizer selection and sizing, isolators versus RABS, blow-fill-seal, washing and depyrogenation tunnels, autoclaves, WFI and pure steam systems, visual inspection, biologics fill-finish, and the equipment for syrups, ointments, creams and tubes.

All 20 guides in this section

Guides marked coming soon are being published in batches; this page links to each one as it goes live.

Frequently asked questions

What is the difference between terminal sterilization and aseptic processing?

Terminal sterilization treats the sealed product in its final container, typically with moist heat, and gives the highest sterility assurance. Aseptic processing sterilizes the product, containers and closures separately and fills them in a Grade A zone; it is used when the product cannot survive terminal sterilization, as with most biologics.

What does the revised EU GMP Annex 1 change for equipment?

The revised Annex 1, in force since August 2023, requires a documented contamination control strategy across the site, expects barrier technologies such as RABS or isolators for aseptic processing, emphasises protecting first air over exposed product, and sets expectations such as pre-use, post-sterilization integrity testing of sterilizing filters (PUPSIT). Equipment design and qualification have to support all of these.

How is Water for Injection (WFI) produced?

WFI has traditionally been made by distillation. Since 2017 the European Pharmacopoeia also allows non-distillation methods based on reverse osmosis combined with other suitable techniques, provided the system is properly validated and monitored. WFI systems are usually paired with pure steam generators for sterilization.

Ready to read pharma differently?

Join the Hello Pharma community for editorial, intelligence and engineering reference from pharma manufacturing.